Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP281513.RAT1vdk8j6OUk4cnFASAaw311lVvBDgKlPD31x1Em6iTM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP281513.RAT1vdk8j6OUk4cnFASAaw311lVvBDgKlPD31x1Em6iTM130_assertion type Assertion NP281513.RAT1vdk8j6OUk4cnFASAaw311lVvBDgKlPD31x1Em6iTM130_head.
- NP281513.RAT1vdk8j6OUk4cnFASAaw311lVvBDgKlPD31x1Em6iTM130_assertion description "[A glutamine (Gln)/arginine (Arg) polymorphism at amino acid residue 192 in PON1 was significantly associated with stroke (P=0.003 in multivariate analysis, including age, sex, LDL, hypertension, diabetes, smoking, and pravastatin treatment as covariates).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP281513.RAT1vdk8j6OUk4cnFASAaw311lVvBDgKlPD31x1Em6iTM130_provenance.
- NP281513.RAT1vdk8j6OUk4cnFASAaw311lVvBDgKlPD31x1Em6iTM130_assertion evidence source_evidence_literature NP281513.RAT1vdk8j6OUk4cnFASAaw311lVvBDgKlPD31x1Em6iTM130_provenance.
- NP281513.RAT1vdk8j6OUk4cnFASAaw311lVvBDgKlPD31x1Em6iTM130_assertion SIO_000772 16239632 NP281513.RAT1vdk8j6OUk4cnFASAaw311lVvBDgKlPD31x1Em6iTM130_provenance.
- NP281513.RAT1vdk8j6OUk4cnFASAaw311lVvBDgKlPD31x1Em6iTM130_assertion wasDerivedFrom befree-20140225 NP281513.RAT1vdk8j6OUk4cnFASAaw311lVvBDgKlPD31x1Em6iTM130_provenance.
- NP281513.RAT1vdk8j6OUk4cnFASAaw311lVvBDgKlPD31x1Em6iTM130_assertion wasGeneratedBy ECO_0000203 NP281513.RAT1vdk8j6OUk4cnFASAaw311lVvBDgKlPD31x1Em6iTM130_provenance.